The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Evolocumab Market Research Report 2025
Synopsis
Evolocumab(trade name Repatha) is a monoclonal antibody medication designed for the treatment of hyperlipidemia.
Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that targets LDL receptors for degradation and its inhibition thereby enhances the liver's ability to remove LDL-C, or "bad" cholesterol, from the blood.
The global Evolocumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Evolocumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Evolocumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Evolocumab include BOCSCI, Carbosynth, TargetMol Chemicals, Chemren Bio-Engineering, DC Chemicals, Hefei Enli Medical Technology, Hefei Hirisun Pharmatech, Hubei Kele Fine Chemical and Hubei Xingcheng Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Evolocumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Evolocumab.
Report Scope
The Evolocumab market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Evolocumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Evolocumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BOCSCI
Carbosynth
TargetMol Chemicals
Chemren Bio-Engineering
DC Chemicals
Hefei Enli Medical Technology
Hefei Hirisun Pharmatech
Hubei Kele Fine Chemical
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Nantong Feiyu Biological Technology
Nantong Hi-Future Biotechnology
Shanghai Biochempartner
Shanghai Loulan Biotechnology
Shanghai Macklin Biochemical
Shanghai Minkai Biotechnology
Shanghai Ruihui Chemical Technology
Shanghai Yifei Biotechnology
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
Taizhou Kerui Bio-Technology
WeiShi Reagent
Wuhan Fortuna Chemical
Wuhan Sunrise Technology Development
Wuhan Weisman Bioengineering
Wuhan Yingnuo Pharmaceutical Technology
Segment by Type
Patent
Generic
Segment by Application
Chemical
Pharmaceutical
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Evolocumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Evolocumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Evolocumab(trade name Repatha) is a monoclonal antibody medication designed for the treatment of hyperlipidemia.
Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that targets LDL receptors for degradation and its inhibition thereby enhances the liver's ability to remove LDL-C, or "bad" cholesterol, from the blood.
The global Evolocumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Evolocumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Evolocumab is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Evolocumab include BOCSCI, Carbosynth, TargetMol Chemicals, Chemren Bio-Engineering, DC Chemicals, Hefei Enli Medical Technology, Hefei Hirisun Pharmatech, Hubei Kele Fine Chemical and Hubei Xingcheng Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Evolocumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Evolocumab.
Report Scope
The Evolocumab market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Evolocumab market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Evolocumab manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BOCSCI
Carbosynth
TargetMol Chemicals
Chemren Bio-Engineering
DC Chemicals
Hefei Enli Medical Technology
Hefei Hirisun Pharmatech
Hubei Kele Fine Chemical
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Nantong Feiyu Biological Technology
Nantong Hi-Future Biotechnology
Shanghai Biochempartner
Shanghai Loulan Biotechnology
Shanghai Macklin Biochemical
Shanghai Minkai Biotechnology
Shanghai Ruihui Chemical Technology
Shanghai Yifei Biotechnology
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
Taizhou Kerui Bio-Technology
WeiShi Reagent
Wuhan Fortuna Chemical
Wuhan Sunrise Technology Development
Wuhan Weisman Bioengineering
Wuhan Yingnuo Pharmaceutical Technology
Segment by Type
Patent
Generic
Segment by Application
Chemical
Pharmaceutical
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Evolocumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Evolocumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Evolocumab Market Overview
1.1 Product Overview and Scope of Evolocumab
1.2 Evolocumab Segment by Type
1.2.1 Global Evolocumab Market Value Comparison by Type (2024-2030)
1.2.2 Patent
1.2.3 Generic
1.3 Evolocumab Segment by Application
1.3.1 Global Evolocumab Market Value by Application: (2024-2030)
1.3.2 Chemical
1.3.3 Pharmaceutical
1.4 Global Evolocumab Market Size Estimates and Forecasts
1.4.1 Global Evolocumab Revenue 2019-2030
1.4.2 Global Evolocumab Sales 2019-2030
1.4.3 Global Evolocumab Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Evolocumab Market Competition by Manufacturers
2.1 Global Evolocumab Sales Market Share by Manufacturers (2019-2024)
2.2 Global Evolocumab Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Evolocumab Average Price by Manufacturers (2019-2024)
2.4 Global Evolocumab Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Evolocumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Evolocumab, Product Type & Application
2.7 Evolocumab Market Competitive Situation and Trends
2.7.1 Evolocumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Evolocumab Players Market Share by Revenue
2.7.3 Global Evolocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Evolocumab Retrospective Market Scenario by Region
3.1 Global Evolocumab Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Evolocumab Global Evolocumab Sales by Region: 2019-2030
3.2.1 Global Evolocumab Sales by Region: 2019-2024
3.2.2 Global Evolocumab Sales by Region: 2025-2030
3.3 Global Evolocumab Global Evolocumab Revenue by Region: 2019-2030
3.3.1 Global Evolocumab Revenue by Region: 2019-2024
3.3.2 Global Evolocumab Revenue by Region: 2025-2030
3.4 North America Evolocumab Market Facts & Figures by Country
3.4.1 North America Evolocumab Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Evolocumab Sales by Country (2019-2030)
3.4.3 North America Evolocumab Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Evolocumab Market Facts & Figures by Country
3.5.1 Europe Evolocumab Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Evolocumab Sales by Country (2019-2030)
3.5.3 Europe Evolocumab Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Evolocumab Market Facts & Figures by Country
3.6.1 Asia Pacific Evolocumab Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Evolocumab Sales by Country (2019-2030)
3.6.3 Asia Pacific Evolocumab Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Evolocumab Market Facts & Figures by Country
3.7.1 Latin America Evolocumab Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Evolocumab Sales by Country (2019-2030)
3.7.3 Latin America Evolocumab Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Evolocumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Evolocumab Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Evolocumab Sales by Country (2019-2030)
3.8.3 Middle East and Africa Evolocumab Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Evolocumab Sales by Type (2019-2030)
4.1.1 Global Evolocumab Sales by Type (2019-2024)
4.1.2 Global Evolocumab Sales by Type (2025-2030)
4.1.3 Global Evolocumab Sales Market Share by Type (2019-2030)
4.2 Global Evolocumab Revenue by Type (2019-2030)
4.2.1 Global Evolocumab Revenue by Type (2019-2024)
4.2.2 Global Evolocumab Revenue by Type (2025-2030)
4.2.3 Global Evolocumab Revenue Market Share by Type (2019-2030)
4.3 Global Evolocumab Price by Type (2019-2030)
5 Segment by Application
5.1 Global Evolocumab Sales by Application (2019-2030)
5.1.1 Global Evolocumab Sales by Application (2019-2024)
5.1.2 Global Evolocumab Sales by Application (2025-2030)
5.1.3 Global Evolocumab Sales Market Share by Application (2019-2030)
5.2 Global Evolocumab Revenue by Application (2019-2030)
5.2.1 Global Evolocumab Revenue by Application (2019-2024)
5.2.2 Global Evolocumab Revenue by Application (2025-2030)
5.2.3 Global Evolocumab Revenue Market Share by Application (2019-2030)
5.3 Global Evolocumab Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BOCSCI
6.1.1 BOCSCI Corporation Information
6.1.2 BOCSCI Description and Business Overview
6.1.3 BOCSCI Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BOCSCI Evolocumab Product Portfolio
6.1.5 BOCSCI Recent Developments/Updates
6.2 Carbosynth
6.2.1 Carbosynth Corporation Information
6.2.2 Carbosynth Description and Business Overview
6.2.3 Carbosynth Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Carbosynth Evolocumab Product Portfolio
6.2.5 Carbosynth Recent Developments/Updates
6.3 TargetMol Chemicals
6.3.1 TargetMol Chemicals Corporation Information
6.3.2 TargetMol Chemicals Description and Business Overview
6.3.3 TargetMol Chemicals Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TargetMol Chemicals Evolocumab Product Portfolio
6.3.5 TargetMol Chemicals Recent Developments/Updates
6.4 Chemren Bio-Engineering
6.4.1 Chemren Bio-Engineering Corporation Information
6.4.2 Chemren Bio-Engineering Description and Business Overview
6.4.3 Chemren Bio-Engineering Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chemren Bio-Engineering Evolocumab Product Portfolio
6.4.5 Chemren Bio-Engineering Recent Developments/Updates
6.5 DC Chemicals
6.5.1 DC Chemicals Corporation Information
6.5.2 DC Chemicals Description and Business Overview
6.5.3 DC Chemicals Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DC Chemicals Evolocumab Product Portfolio
6.5.5 DC Chemicals Recent Developments/Updates
6.6 Hefei Enli Medical Technology
6.6.1 Hefei Enli Medical Technology Corporation Information
6.6.2 Hefei Enli Medical Technology Description and Business Overview
6.6.3 Hefei Enli Medical Technology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hefei Enli Medical Technology Evolocumab Product Portfolio
6.6.5 Hefei Enli Medical Technology Recent Developments/Updates
6.7 Hefei Hirisun Pharmatech
6.6.1 Hefei Hirisun Pharmatech Corporation Information
6.6.2 Hefei Hirisun Pharmatech Description and Business Overview
6.6.3 Hefei Hirisun Pharmatech Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hefei Hirisun Pharmatech Evolocumab Product Portfolio
6.7.5 Hefei Hirisun Pharmatech Recent Developments/Updates
6.8 Hubei Kele Fine Chemical
6.8.1 Hubei Kele Fine Chemical Corporation Information
6.8.2 Hubei Kele Fine Chemical Description and Business Overview
6.8.3 Hubei Kele Fine Chemical Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hubei Kele Fine Chemical Evolocumab Product Portfolio
6.8.5 Hubei Kele Fine Chemical Recent Developments/Updates
6.9 Hubei Xingcheng Biotechnology
6.9.1 Hubei Xingcheng Biotechnology Corporation Information
6.9.2 Hubei Xingcheng Biotechnology Description and Business Overview
6.9.3 Hubei Xingcheng Biotechnology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hubei Xingcheng Biotechnology Evolocumab Product Portfolio
6.9.5 Hubei Xingcheng Biotechnology Recent Developments/Updates
6.10 Hubei Zhongshan Medical Technology
6.10.1 Hubei Zhongshan Medical Technology Corporation Information
6.10.2 Hubei Zhongshan Medical Technology Description and Business Overview
6.10.3 Hubei Zhongshan Medical Technology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hubei Zhongshan Medical Technology Evolocumab Product Portfolio
6.10.5 Hubei Zhongshan Medical Technology Recent Developments/Updates
6.11 Nantong Feiyu Biological Technology
6.11.1 Nantong Feiyu Biological Technology Corporation Information
6.11.2 Nantong Feiyu Biological Technology Evolocumab Description and Business Overview
6.11.3 Nantong Feiyu Biological Technology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nantong Feiyu Biological Technology Evolocumab Product Portfolio
6.11.5 Nantong Feiyu Biological Technology Recent Developments/Updates
6.12 Nantong Hi-Future Biotechnology
6.12.1 Nantong Hi-Future Biotechnology Corporation Information
6.12.2 Nantong Hi-Future Biotechnology Evolocumab Description and Business Overview
6.12.3 Nantong Hi-Future Biotechnology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Nantong Hi-Future Biotechnology Evolocumab Product Portfolio
6.12.5 Nantong Hi-Future Biotechnology Recent Developments/Updates
6.13 Shanghai Biochempartner
6.13.1 Shanghai Biochempartner Corporation Information
6.13.2 Shanghai Biochempartner Evolocumab Description and Business Overview
6.13.3 Shanghai Biochempartner Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shanghai Biochempartner Evolocumab Product Portfolio
6.13.5 Shanghai Biochempartner Recent Developments/Updates
6.14 Shanghai Loulan Biotechnology
6.14.1 Shanghai Loulan Biotechnology Corporation Information
6.14.2 Shanghai Loulan Biotechnology Evolocumab Description and Business Overview
6.14.3 Shanghai Loulan Biotechnology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shanghai Loulan Biotechnology Evolocumab Product Portfolio
6.14.5 Shanghai Loulan Biotechnology Recent Developments/Updates
6.15 Shanghai Macklin Biochemical
6.15.1 Shanghai Macklin Biochemical Corporation Information
6.15.2 Shanghai Macklin Biochemical Evolocumab Description and Business Overview
6.15.3 Shanghai Macklin Biochemical Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shanghai Macklin Biochemical Evolocumab Product Portfolio
6.15.5 Shanghai Macklin Biochemical Recent Developments/Updates
6.16 Shanghai Minkai Biotechnology
6.16.1 Shanghai Minkai Biotechnology Corporation Information
6.16.2 Shanghai Minkai Biotechnology Evolocumab Description and Business Overview
6.16.3 Shanghai Minkai Biotechnology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Shanghai Minkai Biotechnology Evolocumab Product Portfolio
6.16.5 Shanghai Minkai Biotechnology Recent Developments/Updates
6.17 Shanghai Ruihui Chemical Technology
6.17.1 Shanghai Ruihui Chemical Technology Corporation Information
6.17.2 Shanghai Ruihui Chemical Technology Evolocumab Description and Business Overview
6.17.3 Shanghai Ruihui Chemical Technology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Shanghai Ruihui Chemical Technology Evolocumab Product Portfolio
6.17.5 Shanghai Ruihui Chemical Technology Recent Developments/Updates
6.18 Shanghai Yifei Biotechnology
6.18.1 Shanghai Yifei Biotechnology Corporation Information
6.18.2 Shanghai Yifei Biotechnology Evolocumab Description and Business Overview
6.18.3 Shanghai Yifei Biotechnology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shanghai Yifei Biotechnology Evolocumab Product Portfolio
6.18.5 Shanghai Yifei Biotechnology Recent Developments/Updates
6.19 Sichuan Weiqi Biotechnology
6.19.1 Sichuan Weiqi Biotechnology Corporation Information
6.19.2 Sichuan Weiqi Biotechnology Evolocumab Description and Business Overview
6.19.3 Sichuan Weiqi Biotechnology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Sichuan Weiqi Biotechnology Evolocumab Product Portfolio
6.19.5 Sichuan Weiqi Biotechnology Recent Developments/Updates
6.20 Taizhou KEDE Chemical
6.20.1 Taizhou KEDE Chemical Corporation Information
6.20.2 Taizhou KEDE Chemical Evolocumab Description and Business Overview
6.20.3 Taizhou KEDE Chemical Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Taizhou KEDE Chemical Evolocumab Product Portfolio
6.20.5 Taizhou KEDE Chemical Recent Developments/Updates
6.21 Taizhou Kerui Bio-Technology
6.21.1 Taizhou Kerui Bio-Technology Corporation Information
6.21.2 Taizhou Kerui Bio-Technology Evolocumab Description and Business Overview
6.21.3 Taizhou Kerui Bio-Technology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Taizhou Kerui Bio-Technology Evolocumab Product Portfolio
6.21.5 Taizhou Kerui Bio-Technology Recent Developments/Updates
6.22 WeiShi Reagent
6.22.1 WeiShi Reagent Corporation Information
6.22.2 WeiShi Reagent Evolocumab Description and Business Overview
6.22.3 WeiShi Reagent Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.22.4 WeiShi Reagent Evolocumab Product Portfolio
6.22.5 WeiShi Reagent Recent Developments/Updates
6.23 Wuhan Fortuna Chemical
6.23.1 Wuhan Fortuna Chemical Corporation Information
6.23.2 Wuhan Fortuna Chemical Evolocumab Description and Business Overview
6.23.3 Wuhan Fortuna Chemical Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Wuhan Fortuna Chemical Evolocumab Product Portfolio
6.23.5 Wuhan Fortuna Chemical Recent Developments/Updates
6.24 Wuhan Sunrise Technology Development
6.24.1 Wuhan Sunrise Technology Development Corporation Information
6.24.2 Wuhan Sunrise Technology Development Evolocumab Description and Business Overview
6.24.3 Wuhan Sunrise Technology Development Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Wuhan Sunrise Technology Development Evolocumab Product Portfolio
6.24.5 Wuhan Sunrise Technology Development Recent Developments/Updates
6.25 Wuhan Weisman Bioengineering
6.25.1 Wuhan Weisman Bioengineering Corporation Information
6.25.2 Wuhan Weisman Bioengineering Evolocumab Description and Business Overview
6.25.3 Wuhan Weisman Bioengineering Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Wuhan Weisman Bioengineering Evolocumab Product Portfolio
6.25.5 Wuhan Weisman Bioengineering Recent Developments/Updates
6.26 Wuhan Yingnuo Pharmaceutical Technology
6.26.1 Wuhan Yingnuo Pharmaceutical Technology Corporation Information
6.26.2 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Description and Business Overview
6.26.3 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Product Portfolio
6.26.5 Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Evolocumab Industry Chain Analysis
7.2 Evolocumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Evolocumab Production Mode & Process
7.4 Evolocumab Sales and Marketing
7.4.1 Evolocumab Sales Channels
7.4.2 Evolocumab Distributors
7.5 Evolocumab Customers
8 Evolocumab Market Dynamics
8.1 Evolocumab Industry Trends
8.2 Evolocumab Market Drivers
8.3 Evolocumab Market Challenges
8.4 Evolocumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Evolocumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Evolocumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Evolocumab Market Competitive Situation by Manufacturers in 2023
Table 4. Global Evolocumab Sales (Kg) of Key Manufacturers (2019-2024)
Table 5. Global Evolocumab Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Evolocumab Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Evolocumab Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Evolocumab Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Evolocumab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Evolocumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Evolocumab, Product Type & Application
Table 12. Global Key Manufacturers of Evolocumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Evolocumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Evolocumab as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Evolocumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Evolocumab Sales by Region (2019-2024) & (Kg)
Table 18. Global Evolocumab Sales Market Share by Region (2019-2024)
Table 19. Global Evolocumab Sales by Region (2025-2030) & (Kg)
Table 20. Global Evolocumab Sales Market Share by Region (2025-2030)
Table 21. Global Evolocumab Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Evolocumab Revenue Market Share by Region (2019-2024)
Table 23. Global Evolocumab Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Evolocumab Revenue Market Share by Region (2025-2030)
Table 25. North America Evolocumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Evolocumab Sales by Country (2019-2024) & (Kg)
Table 27. North America Evolocumab Sales by Country (2025-2030) & (Kg)
Table 28. North America Evolocumab Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Evolocumab Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Evolocumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Evolocumab Sales by Country (2019-2024) & (Kg)
Table 32. Europe Evolocumab Sales by Country (2025-2030) & (Kg)
Table 33. Europe Evolocumab Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Evolocumab Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Evolocumab Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Evolocumab Sales by Region (2019-2024) & (Kg)
Table 37. Asia Pacific Evolocumab Sales by Region (2025-2030) & (Kg)
Table 38. Asia Pacific Evolocumab Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Evolocumab Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Evolocumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Evolocumab Sales by Country (2019-2024) & (Kg)
Table 42. Latin America Evolocumab Sales by Country (2025-2030) & (Kg)
Table 43. Latin America Evolocumab Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Evolocumab Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Evolocumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Evolocumab Sales by Country (2019-2024) & (Kg)
Table 47. Middle East & Africa Evolocumab Sales by Country (2025-2030) & (Kg)
Table 48. Middle East & Africa Evolocumab Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Evolocumab Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Evolocumab Sales (Kg) by Type (2019-2024)
Table 51. Global Evolocumab Sales (Kg) by Type (2025-2030)
Table 52. Global Evolocumab Sales Market Share by Type (2019-2024)
Table 53. Global Evolocumab Sales Market Share by Type (2025-2030)
Table 54. Global Evolocumab Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Evolocumab Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Evolocumab Revenue Market Share by Type (2019-2024)
Table 57. Global Evolocumab Revenue Market Share by Type (2025-2030)
Table 58. Global Evolocumab Price (US$/Kg) by Type (2019-2024)
Table 59. Global Evolocumab Price (US$/Kg) by Type (2025-2030)
Table 60. Global Evolocumab Sales (Kg) by Application (2019-2024)
Table 61. Global Evolocumab Sales (Kg) by Application (2025-2030)
Table 62. Global Evolocumab Sales Market Share by Application (2019-2024)
Table 63. Global Evolocumab Sales Market Share by Application (2025-2030)
Table 64. Global Evolocumab Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Evolocumab Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Evolocumab Revenue Market Share by Application (2019-2024)
Table 67. Global Evolocumab Revenue Market Share by Application (2025-2030)
Table 68. Global Evolocumab Price (US$/Kg) by Application (2019-2024)
Table 69. Global Evolocumab Price (US$/Kg) by Application (2025-2030)
Table 70. BOCSCI Corporation Information
Table 71. BOCSCI Description and Business Overview
Table 72. BOCSCI Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. BOCSCI Evolocumab Product
Table 74. BOCSCI Recent Developments/Updates
Table 75. Carbosynth Corporation Information
Table 76. Carbosynth Description and Business Overview
Table 77. Carbosynth Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Carbosynth Evolocumab Product
Table 79. Carbosynth Recent Developments/Updates
Table 80. TargetMol Chemicals Corporation Information
Table 81. TargetMol Chemicals Description and Business Overview
Table 82. TargetMol Chemicals Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. TargetMol Chemicals Evolocumab Product
Table 84. TargetMol Chemicals Recent Developments/Updates
Table 85. Chemren Bio-Engineering Corporation Information
Table 86. Chemren Bio-Engineering Description and Business Overview
Table 87. Chemren Bio-Engineering Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Chemren Bio-Engineering Evolocumab Product
Table 89. Chemren Bio-Engineering Recent Developments/Updates
Table 90. DC Chemicals Corporation Information
Table 91. DC Chemicals Description and Business Overview
Table 92. DC Chemicals Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. DC Chemicals Evolocumab Product
Table 94. DC Chemicals Recent Developments/Updates
Table 95. Hefei Enli Medical Technology Corporation Information
Table 96. Hefei Enli Medical Technology Description and Business Overview
Table 97. Hefei Enli Medical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Hefei Enli Medical Technology Evolocumab Product
Table 99. Hefei Enli Medical Technology Recent Developments/Updates
Table 100. Hefei Hirisun Pharmatech Corporation Information
Table 101. Hefei Hirisun Pharmatech Description and Business Overview
Table 102. Hefei Hirisun Pharmatech Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Hefei Hirisun Pharmatech Evolocumab Product
Table 104. Hefei Hirisun Pharmatech Recent Developments/Updates
Table 105. Hubei Kele Fine Chemical Corporation Information
Table 106. Hubei Kele Fine Chemical Description and Business Overview
Table 107. Hubei Kele Fine Chemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Hubei Kele Fine Chemical Evolocumab Product
Table 109. Hubei Kele Fine Chemical Recent Developments/Updates
Table 110. Hubei Xingcheng Biotechnology Corporation Information
Table 111. Hubei Xingcheng Biotechnology Description and Business Overview
Table 112. Hubei Xingcheng Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Hubei Xingcheng Biotechnology Evolocumab Product
Table 114. Hubei Xingcheng Biotechnology Recent Developments/Updates
Table 115. Hubei Zhongshan Medical Technology Corporation Information
Table 116. Hubei Zhongshan Medical Technology Description and Business Overview
Table 117. Hubei Zhongshan Medical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Hubei Zhongshan Medical Technology Evolocumab Product
Table 119. Hubei Zhongshan Medical Technology Recent Developments/Updates
Table 120. Nantong Feiyu Biological Technology Corporation Information
Table 121. Nantong Feiyu Biological Technology Description and Business Overview
Table 122. Nantong Feiyu Biological Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Nantong Feiyu Biological Technology Evolocumab Product
Table 124. Nantong Feiyu Biological Technology Recent Developments/Updates
Table 125. Nantong Hi-Future Biotechnology Corporation Information
Table 126. Nantong Hi-Future Biotechnology Description and Business Overview
Table 127. Nantong Hi-Future Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Nantong Hi-Future Biotechnology Evolocumab Product
Table 129. Nantong Hi-Future Biotechnology Recent Developments/Updates
Table 130. Shanghai Biochempartner Corporation Information
Table 131. Shanghai Biochempartner Description and Business Overview
Table 132. Shanghai Biochempartner Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Shanghai Biochempartner Evolocumab Product
Table 134. Shanghai Biochempartner Recent Developments/Updates
Table 135. Shanghai Loulan Biotechnology Corporation Information
Table 136. Shanghai Loulan Biotechnology Description and Business Overview
Table 137. Shanghai Loulan Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 138. Shanghai Loulan Biotechnology Evolocumab Product
Table 139. Shanghai Loulan Biotechnology Recent Developments/Updates
Table 140. Shanghai Macklin Biochemical Corporation Information
Table 141. Shanghai Macklin Biochemical Description and Business Overview
Table 142. Shanghai Macklin Biochemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 143. Shanghai Macklin Biochemical Evolocumab Product
Table 144. Shanghai Macklin Biochemical Recent Developments/Updates
Table 145. Shanghai Minkai Biotechnology Corporation Information
Table 146. Shanghai Minkai Biotechnology Description and Business Overview
Table 147. Shanghai Minkai Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 148. Shanghai Minkai Biotechnology Evolocumab Product
Table 149. Shanghai Minkai Biotechnology Recent Developments/Updates
Table 150. Shanghai Ruihui Chemical Technology Corporation Information
Table 151. Shanghai Ruihui Chemical Technology Description and Business Overview
Table 152. Shanghai Ruihui Chemical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 153. Shanghai Ruihui Chemical Technology Evolocumab Product
Table 154. Shanghai Ruihui Chemical Technology Recent Developments/Updates
Table 155. Shanghai Yifei Biotechnology Corporation Information
Table 156. Shanghai Yifei Biotechnology Description and Business Overview
Table 157. Shanghai Yifei Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 158. Shanghai Yifei Biotechnology Evolocumab Product
Table 159. Shanghai Yifei Biotechnology Recent Developments/Updates
Table 160. Sichuan Weiqi Biotechnology Corporation Information
Table 161. Sichuan Weiqi Biotechnology Description and Business Overview
Table 162. Sichuan Weiqi Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 163. Sichuan Weiqi Biotechnology Evolocumab Product
Table 164. Sichuan Weiqi Biotechnology Recent Developments/Updates
Table 165. Taizhou KEDE Chemical Corporation Information
Table 166. Taizhou KEDE Chemical Description and Business Overview
Table 167. Taizhou KEDE Chemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 168. Taizhou KEDE Chemical Evolocumab Product
Table 169. Taizhou KEDE Chemical Recent Developments/Updates
Table 170. Taizhou Kerui Bio-Technology Corporation Information
Table 171. Taizhou Kerui Bio-Technology Description and Business Overview
Table 172. Taizhou Kerui Bio-Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 173. Taizhou Kerui Bio-Technology Evolocumab Product
Table 174. Taizhou Kerui Bio-Technology Recent Developments/Updates
Table 175. WeiShi Reagent Corporation Information
Table 176. WeiShi Reagent Description and Business Overview
Table 177. WeiShi Reagent Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 178. WeiShi Reagent Evolocumab Product
Table 179. WeiShi Reagent Recent Developments/Updates
Table 180. Wuhan Fortuna Chemical Corporation Information
Table 181. Wuhan Fortuna Chemical Description and Business Overview
Table 182. Wuhan Fortuna Chemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 183. Wuhan Fortuna Chemical Evolocumab Product
Table 184. Wuhan Fortuna Chemical Recent Developments/Updates
Table 185. Wuhan Sunrise Technology Development Corporation Information
Table 186. Wuhan Sunrise Technology Development Description and Business Overview
Table 187. Wuhan Sunrise Technology Development Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 188. Wuhan Sunrise Technology Development Evolocumab Product
Table 189. Wuhan Sunrise Technology Development Recent Developments/Updates
Table 190. Wuhan Weisman Bioengineering Corporation Information
Table 191. Wuhan Weisman Bioengineering Description and Business Overview
Table 192. Wuhan Weisman Bioengineering Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 193. Wuhan Weisman Bioengineering Evolocumab Product
Table 194. Wuhan Weisman Bioengineering Recent Developments/Updates
Table 195. Wuhan Yingnuo Pharmaceutical Technology Corporation Information
Table 196. Wuhan Yingnuo Pharmaceutical Technology Description and Business Overview
Table 197. Wuhan Yingnuo Pharmaceutical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 198. Wuhan Yingnuo Pharmaceutical Technology Evolocumab Product
Table 199. Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Evolocumab Distributors List
Table 203. Evolocumab Customers List
Table 204. Evolocumab Market Trends
Table 205. Evolocumab Market Drivers
Table 206. Evolocumab Market Challenges
Table 207. Evolocumab Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Evolocumab
Figure 2. Global Evolocumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Evolocumab Market Share by Type in 2023 & 2030
Figure 4. Patent Product Picture
Figure 5. Generic Product Picture
Figure 6. Global Evolocumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Evolocumab Market Share by Application in 2023 & 2030
Figure 8. Chemical
Figure 9. Pharmaceutical
Figure 10. Global Evolocumab Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Evolocumab Market Size (2019-2030) & (US$ Million)
Figure 12. Global Evolocumab Sales (2019-2030) & (Kg)
Figure 13. Global Evolocumab Average Price (US$/Kg) & (2019-2030)
Figure 14. Evolocumab Report Years Considered
Figure 15. Evolocumab Sales Share by Manufacturers in 2023
Figure 16. Global Evolocumab Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Evolocumab Players: Market Share by Revenue in 2023
Figure 18. Evolocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Evolocumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Evolocumab Sales Market Share by Country (2019-2030)
Figure 21. North America Evolocumab Revenue Market Share by Country (2019-2030)
Figure 22. United States Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Evolocumab Sales Market Share by Country (2019-2030)
Figure 25. Europe Evolocumab Revenue Market Share by Country (2019-2030)
Figure 26. Germany Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Evolocumab Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Evolocumab Revenue Market Share by Region (2019-2030)
Figure 33. China Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Evolocumab Sales Market Share by Country (2019-2030)
Figure 43. Latin America Evolocumab Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Evolocumab Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Evolocumab Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Evolocumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Evolocumab by Type (2019-2030)
Figure 53. Global Revenue Market Share of Evolocumab by Type (2019-2030)
Figure 54. Global Evolocumab Price (US$/Kg) by Type (2019-2030)
Figure 55. Global Sales Market Share of Evolocumab by Application (2019-2030)
Figure 56. Global Revenue Market Share of Evolocumab by Application (2019-2030)
Figure 57. Global Evolocumab Price (US$/Kg) by Application (2019-2030)
Figure 58. Evolocumab Value Chain
Figure 59. Evolocumab Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
